Human papillomavirus 16 (HPV16) and HPV52 E6 ‐specific immunity in HIV‐infected adults on combination antiretroviral therapy
ConclusionsHPV16 and HPV52 E6‐specific IFN‐γ T‐cell responses, a correlate of protective immunity, were detected more frequently among HIV‐infected patients who achieved optimal immune recovery on cART (26.5%) compared with those with suboptimal recovery (6.3%).
Source: HIV Medicine - Category: Infectious Diseases Authors: CY Leng, HC Low, LL Chua, ML Chong, H Sulaiman, I Azwa, JM Roberts, A Kamarulzaman, R Rajasuriar, YL Woo Tags: Original Research Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Genital Warts | Human Papillomavirus (HPV) | Infectious Diseases | Oral Cancer | Study